MDT

83.58

-0.61%↓

VEEV

225.8

+0.45%↑

A

105.71

+0.08%↑

WBA

10.98

-0.18%↓

CHE

548.09

-0.97%↓

MDT

83.58

-0.61%↓

VEEV

225.8

+0.45%↑

A

105.71

+0.08%↑

WBA

10.98

-0.18%↓

CHE

548.09

-0.97%↓

MDT

83.58

-0.61%↓

VEEV

225.8

+0.45%↑

A

105.71

+0.08%↑

WBA

10.98

-0.18%↓

CHE

548.09

-0.97%↓

MDT

83.58

-0.61%↓

VEEV

225.8

+0.45%↑

A

105.71

+0.08%↑

WBA

10.98

-0.18%↓

CHE

548.09

-0.97%↓

MDT

83.58

-0.61%↓

VEEV

225.8

+0.45%↑

A

105.71

+0.08%↑

WBA

10.98

-0.18%↓

CHE

548.09

-0.97%↓

Search

Tilray Inc

Open

BrancheGesundheitswesen

0.49 11.36

Übersicht

Veränderung der Aktienkurses

24h

Aktuell

Min

0.43

Max

0.5

Schlüsselkennzahlen

By Trading Economics

Einkommen

-704M

-789M

Verkäufe

-118M

186M

EPS

-0.869

Gewinnspanne

-424.931

Angestellte

2,650

EBITDA

-585M

-626M

Empfehlungen

By TipRanks

Empfehlungen

Buy

12-Monats-Prognose

+89.8% upside

Marktstatistiken

By TradingEconomics

Marktkapitalisierung

-582M

446M

Vorheriger Eröffnungskurs

-10.87

Vorheriger Schlusskurs

0.49

Technischer Score

By Trading Central

Vertrauen

Weak Bullish Evidence

Tilray Inc Chart

Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.

Ähnliche Nachrichten

16. Mai 2024, 18:13 UTC

Wichtige Markttreiber

Canopy Growth, Tilray Shares Rise After DOJ Proposes Marijuana Reclassification

8. Apr. 2025, 12:06 UTC

Market Talk

Tilray Reckons Sales Won't Be Dented by Tariffs -- Market Talk

14. Mai 2024, 13:34 UTC

Ergebnisse
Heiße Aktien

Stocks to Watch Tuesday: AMC, GameStop, Alibaba, Home Depot -- WSJ

1. Mai 2024, 13:48 UTC

Heiße Aktien

Stocks to Watch Wednesday: Starbucks, Pfizer, CVS, Amazon -- WSJ

Peer-Vergleich

Kursveränderung

Tilray Inc Prognose

Kursziel

By TipRanks

89.8% Vorteil

12-Monats-Prognose

Durchschnitt 0.93 USD  89.8%

Hoch 1.5 USD

Tief 0.6 USD

Basierend auf 6 Wall-Street-Analysten, die in den letzten 3 Monaten 12-Monats-Kursziele für Tilray Inc – Dist angeboten haben.

Rating-Konsens

By TipRanks

Buy

6 ratings

2

Buy

4

Halten

0

Sell

Technischer Score

By Trading Central

0.4637 / 0.52Unterstützung & Widerstand

Kurzfristig

Weak Bullish Evidence

Mittelfristig

No Evidence

Langfristig

No Evidence

Finanzen

Vertriebs- und Verwaltungskosten

Betriebsaufwand

Gewinn vor Steuern

Verkäufe

Umsatzkosten

Bruttogewinn aus dem Verkauf

Zinsaufwand für Schulden

EBITDA

Betriebsergebnis

$

Über Tilray Inc

Tilray Brands, Inc., a lifestyle consumer products company, engages in the research, cultivation, processing, and distribution of medical cannabis products in Canada, the United States, Europe, Australia, New Zealand, Latin America, and internationally. The company operates through four segments: Beverage Alcohol, Cannabis, Distribution, and Wellness. It also offers medical and adult-use cannabis products; purchases and resells pharmaceutical and wellness products; and produces, markets, sells, and distributes beverage alcohol products, and hemp-based food and other wellness products. The company offers its products under the Tilray, Aphria, Broken Coast, Symbios, Navcora, Charlotte's Web, Montauk Brewing, Shock Top, 10 Barrell, Breckenridge Brewery, SweetWater Brewing, Breckenridge Distillery, Blue Point Brewing, Broken Coast, Redecan, XMG, Manitoba Harvest, CC Pharma, Good Supply, Solei, Mollo, Chowie Wowie, Original Stash, Canaca, RIFF, Bake Sale, The Batch, HEXO, Alpine Beer Company, Green Flash, Hiball Energy, Redhook Brewery, Square Mile Cider, Widmer Brothers Brewing, Runner's High Brewing Company, Happy Flower, and Fresh Hemp Foods brands. It sells its products to retailers, wholesalers, patients, physicians, hospitals, pharmacies, researchers, and governments, as well as direct to consumers. The company was formerly known as Tilray, Inc. and changed its name to Tilray Brands, Inc. in January 2022. Tilray Brands, Inc. is headquartered in Leamington, Canada.